nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—ABCC4—Fluorouracil—head and neck cancer	0.0559	0.232	CbGbCtD
Sunitinib—ABCC2—Vinblastine—head and neck cancer	0.0308	0.128	CbGbCtD
Sunitinib—ABCG2—Fluorouracil—head and neck cancer	0.0301	0.125	CbGbCtD
Sunitinib—ABCC2—Docetaxel—head and neck cancer	0.0254	0.105	CbGbCtD
Sunitinib—ABCG2—Docetaxel—head and neck cancer	0.023	0.0952	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.017	0.0703	CbGbCtD
Sunitinib—CYP3A7—Docetaxel—head and neck cancer	0.017	0.0703	CbGbCtD
Sunitinib—CYP3A5—Docetaxel—head and neck cancer	0.0127	0.0528	CbGbCtD
Sunitinib—ABCB1—Vinblastine—head and neck cancer	0.01	0.0417	CbGbCtD
Sunitinib—ABCB1—Docetaxel—head and neck cancer	0.00828	0.0343	CbGbCtD
Sunitinib—CYP3A4—Vinblastine—head and neck cancer	0.00602	0.025	CbGbCtD
Sunitinib—CYP3A4—Docetaxel—head and neck cancer	0.00496	0.0206	CbGbCtD
Sunitinib—CHEK2—Vindesine—Vinblastine—head and neck cancer	0.00167	0.317	CbGdCrCtD
Sunitinib—CHEK2—Paclitaxel—Docetaxel—head and neck cancer	0.00164	0.312	CbGdCrCtD
Sunitinib—CHEK2—Vinorelbine—Vinblastine—head and neck cancer	0.00105	0.2	CbGdCrCtD
Sunitinib—Oral candidiasis—Docetaxel—head and neck cancer	0.000919	0.00553	CcSEcCtD
Sunitinib—Cerebrovascular accident—Vinblastine—head and neck cancer	0.000912	0.00549	CcSEcCtD
Sunitinib—Embolism—Docetaxel—head and neck cancer	0.000909	0.00547	CcSEcCtD
Sunitinib—Hepatic failure—Hydroxyurea—head and neck cancer	0.000907	0.00546	CcSEcCtD
Sunitinib—Nail disorder—Docetaxel—head and neck cancer	0.0009	0.00541	CcSEcCtD
Sunitinib—CHEK2—Vincristine—Vinblastine—head and neck cancer	0.0009	0.171	CbGdCrCtD
Sunitinib—Cellulitis—Fluorouracil—head and neck cancer	0.000889	0.00535	CcSEcCtD
Sunitinib—Renal failure acute—Hydroxyurea—head and neck cancer	0.000883	0.00531	CcSEcCtD
Sunitinib—Lacrimation increased—Fluorouracil—head and neck cancer	0.000877	0.00528	CcSEcCtD
Sunitinib—Laryngeal pain—Docetaxel—head and neck cancer	0.000856	0.00515	CcSEcCtD
Sunitinib—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.000853	0.00513	CcSEcCtD
Sunitinib—Haemoglobin decreased—Docetaxel—head and neck cancer	0.000848	0.0051	CcSEcCtD
Sunitinib—Face oedema—Hydroxyurea—head and neck cancer	0.000787	0.00474	CcSEcCtD
Sunitinib—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.000764	0.0046	CcSEcCtD
Sunitinib—Pleural effusion—Docetaxel—head and neck cancer	0.000762	0.00458	CcSEcCtD
Sunitinib—Rash erythematous—Docetaxel—head and neck cancer	0.000762	0.00458	CcSEcCtD
Sunitinib—Hepatotoxicity—Docetaxel—head and neck cancer	0.000756	0.00455	CcSEcCtD
Sunitinib—Oesophagitis—Fluorouracil—head and neck cancer	0.000739	0.00444	CcSEcCtD
Sunitinib—Rash maculo-papular—Fluorouracil—head and neck cancer	0.000735	0.00442	CcSEcCtD
Sunitinib—Pancytopenia—Vinblastine—head and neck cancer	0.000734	0.00442	CcSEcCtD
Sunitinib—Myocardial ischaemia—Docetaxel—head and neck cancer	0.000726	0.00437	CcSEcCtD
Sunitinib—Ageusia—Docetaxel—head and neck cancer	0.00072	0.00433	CcSEcCtD
Sunitinib—Sepsis—Fluorouracil—head and neck cancer	0.000702	0.00422	CcSEcCtD
Sunitinib—Pancreatitis—Hydroxyurea—head and neck cancer	0.000691	0.00416	CcSEcCtD
Sunitinib—Depression—Vinblastine—head and neck cancer	0.000687	0.00413	CcSEcCtD
Sunitinib—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000679	0.00409	CcSEcCtD
Sunitinib—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000675	0.00406	CcSEcCtD
Sunitinib—Pancytopenia—Hydroxyurea—head and neck cancer	0.000669	0.00403	CcSEcCtD
Sunitinib—Neutropenia—Hydroxyurea—head and neck cancer	0.000659	0.00396	CcSEcCtD
Sunitinib—Oropharyngeal pain—Docetaxel—head and neck cancer	0.000642	0.00386	CcSEcCtD
Sunitinib—Lacrimation increased—Docetaxel—head and neck cancer	0.000633	0.00381	CcSEcCtD
Sunitinib—Infestation—Hydroxyurea—head and neck cancer	0.000628	0.00378	CcSEcCtD
Sunitinib—Infestation NOS—Hydroxyurea—head and neck cancer	0.000628	0.00378	CcSEcCtD
Sunitinib—Haemoglobin—Vinblastine—head and neck cancer	0.000622	0.00374	CcSEcCtD
Sunitinib—Haemorrhage—Vinblastine—head and neck cancer	0.000619	0.00372	CcSEcCtD
Sunitinib—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000617	0.00371	CcSEcCtD
Sunitinib—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000616	0.00371	CcSEcCtD
Sunitinib—Hypoaesthesia—Vinblastine—head and neck cancer	0.000615	0.0037	CcSEcCtD
Sunitinib—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000614	0.00369	CcSEcCtD
Sunitinib—Stomatitis—Hydroxyurea—head and neck cancer	0.000612	0.00368	CcSEcCtD
Sunitinib—Bone pain—Docetaxel—head and neck cancer	0.000609	0.00366	CcSEcCtD
Sunitinib—Cardiac failure—Fluorouracil—head and neck cancer	0.000601	0.00362	CcSEcCtD
Sunitinib—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000594	0.00358	CcSEcCtD
Sunitinib—Respiratory failure—Docetaxel—head and neck cancer	0.000594	0.00358	CcSEcCtD
Sunitinib—Pulmonary embolism—Docetaxel—head and neck cancer	0.000584	0.00351	CcSEcCtD
Sunitinib—Blood pressure increased—Docetaxel—head and neck cancer	0.000584	0.00351	CcSEcCtD
Sunitinib—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000584	0.00351	CcSEcCtD
Sunitinib—Haemoglobin—Hydroxyurea—head and neck cancer	0.000567	0.00341	CcSEcCtD
Sunitinib—Influenza like illness—Docetaxel—head and neck cancer	0.000567	0.00341	CcSEcCtD
Sunitinib—Haemorrhage—Hydroxyurea—head and neck cancer	0.000564	0.00339	CcSEcCtD
Sunitinib—Candida infection—Docetaxel—head and neck cancer	0.000557	0.00335	CcSEcCtD
Sunitinib—Skin exfoliation—Docetaxel—head and neck cancer	0.000557	0.00335	CcSEcCtD
Sunitinib—Alopecia—Vinblastine—head and neck cancer	0.000547	0.00329	CcSEcCtD
Sunitinib—Dry skin—Fluorouracil—head and neck cancer	0.000538	0.00324	CcSEcCtD
Sunitinib—Oesophagitis—Docetaxel—head and neck cancer	0.000533	0.00321	CcSEcCtD
Sunitinib—Neoplasm—Docetaxel—head and neck cancer	0.000528	0.00317	CcSEcCtD
Sunitinib—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000525	0.00316	CcSEcCtD
Sunitinib—Pulmonary oedema—Docetaxel—head and neck cancer	0.000519	0.00312	CcSEcCtD
Sunitinib—Muscular weakness—Fluorouracil—head and neck cancer	0.000518	0.00311	CcSEcCtD
Sunitinib—Angiopathy—Hydroxyurea—head and neck cancer	0.000512	0.00308	CcSEcCtD
Sunitinib—Dysphagia—Fluorouracil—head and neck cancer	0.000507	0.00305	CcSEcCtD
Sunitinib—Sepsis—Docetaxel—head and neck cancer	0.000506	0.00305	CcSEcCtD
Sunitinib—Chills—Hydroxyurea—head and neck cancer	0.000506	0.00304	CcSEcCtD
Sunitinib—Alopecia—Hydroxyurea—head and neck cancer	0.000498	0.003	CcSEcCtD
Sunitinib—Anaemia—Vinblastine—head and neck cancer	0.000498	0.00299	CcSEcCtD
Sunitinib—Erythema—Hydroxyurea—head and neck cancer	0.000491	0.00295	CcSEcCtD
Sunitinib—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000487	0.00293	CcSEcCtD
Sunitinib—Leukopenia—Vinblastine—head and neck cancer	0.000482	0.0029	CcSEcCtD
Sunitinib—Pancytopenia—Fluorouracil—head and neck cancer	0.000482	0.0029	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000471	0.00284	CcSEcCtD
Sunitinib—Hepatic failure—Docetaxel—head and neck cancer	0.000471	0.00284	CcSEcCtD
Sunitinib—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000467	0.00281	CcSEcCtD
Sunitinib—Convulsion—Vinblastine—head and neck cancer	0.000467	0.00281	CcSEcCtD
Sunitinib—Hypertension—Vinblastine—head and neck cancer	0.000465	0.0028	CcSEcCtD
Sunitinib—Pneumonia—Fluorouracil—head and neck cancer	0.000455	0.00274	CcSEcCtD
Sunitinib—Anaemia—Hydroxyurea—head and neck cancer	0.000454	0.00273	CcSEcCtD
Sunitinib—Hot flush—Docetaxel—head and neck cancer	0.000453	0.00272	CcSEcCtD
Sunitinib—Infestation NOS—Fluorouracil—head and neck cancer	0.000452	0.00272	CcSEcCtD
Sunitinib—Infestation—Fluorouracil—head and neck cancer	0.000452	0.00272	CcSEcCtD
Sunitinib—Menopausal symptoms—Docetaxel—head and neck cancer	0.000449	0.0027	CcSEcCtD
Sunitinib—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000446	0.00268	CcSEcCtD
Sunitinib—Renal impairment—Docetaxel—head and neck cancer	0.000445	0.00268	CcSEcCtD
Sunitinib—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000443	0.00267	CcSEcCtD
Sunitinib—Dermatitis bullous—Docetaxel—head and neck cancer	0.000443	0.00267	CcSEcCtD
Sunitinib—Stomatitis—Fluorouracil—head and neck cancer	0.000441	0.00265	CcSEcCtD
Sunitinib—Urinary tract infection—Fluorouracil—head and neck cancer	0.00044	0.00264	CcSEcCtD
Sunitinib—Leukopenia—Hydroxyurea—head and neck cancer	0.00044	0.00264	CcSEcCtD
Sunitinib—Cardiac failure—Docetaxel—head and neck cancer	0.000434	0.00261	CcSEcCtD
Sunitinib—Thrombocytopenia—Vinblastine—head and neck cancer	0.00043	0.00259	CcSEcCtD
Sunitinib—Epistaxis—Fluorouracil—head and neck cancer	0.000427	0.00257	CcSEcCtD
Sunitinib—Convulsion—Hydroxyurea—head and neck cancer	0.000425	0.00256	CcSEcCtD
Sunitinib—Hyponatraemia—Docetaxel—head and neck cancer	0.000425	0.00256	CcSEcCtD
Sunitinib—Pain in extremity—Docetaxel—head and neck cancer	0.000424	0.00255	CcSEcCtD
Sunitinib—Anorexia—Vinblastine—head and neck cancer	0.000419	0.00252	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000415	0.0025	CcSEcCtD
Sunitinib—Haemoglobin—Fluorouracil—head and neck cancer	0.000408	0.00246	CcSEcCtD
Sunitinib—Haemorrhage—Fluorouracil—head and neck cancer	0.000406	0.00244	CcSEcCtD
Sunitinib—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000404	0.00243	CcSEcCtD
Sunitinib—Oedema—Hydroxyurea—head and neck cancer	0.000401	0.00241	CcSEcCtD
Sunitinib—Infection—Hydroxyurea—head and neck cancer	0.000398	0.0024	CcSEcCtD
Sunitinib—Paraesthesia—Vinblastine—head and neck cancer	0.000395	0.00237	CcSEcCtD
Sunitinib—Dehydration—Docetaxel—head and neck cancer	0.000394	0.00237	CcSEcCtD
Sunitinib—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000393	0.00236	CcSEcCtD
Sunitinib—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000392	0.00236	CcSEcCtD
Sunitinib—Liver function test abnormal—Docetaxel—head and neck cancer	0.000391	0.00235	CcSEcCtD
Sunitinib—Skin disorder—Hydroxyurea—head and neck cancer	0.000389	0.00234	CcSEcCtD
Sunitinib—Dry skin—Docetaxel—head and neck cancer	0.000388	0.00234	CcSEcCtD
Sunitinib—Abdominal pain upper—Docetaxel—head and neck cancer	0.000387	0.00233	CcSEcCtD
Sunitinib—Anorexia—Hydroxyurea—head and neck cancer	0.000382	0.0023	CcSEcCtD
Sunitinib—Decreased appetite—Vinblastine—head and neck cancer	0.000382	0.0023	CcSEcCtD
Sunitinib—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000381	0.00229	CcSEcCtD
Sunitinib—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000381	0.00229	CcSEcCtD
Sunitinib—Nasopharyngitis—Docetaxel—head and neck cancer	0.000379	0.00228	CcSEcCtD
Sunitinib—Pain—Vinblastine—head and neck cancer	0.000376	0.00226	CcSEcCtD
Sunitinib—Constipation—Vinblastine—head and neck cancer	0.000376	0.00226	CcSEcCtD
Sunitinib—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000374	0.00225	CcSEcCtD
Sunitinib—Dysphagia—Docetaxel—head and neck cancer	0.000366	0.0022	CcSEcCtD
Sunitinib—Arrhythmia—Fluorouracil—head and neck cancer	0.000363	0.00218	CcSEcCtD
Sunitinib—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000359	0.00216	CcSEcCtD
Sunitinib—Alopecia—Fluorouracil—head and neck cancer	0.000359	0.00216	CcSEcCtD
Sunitinib—Dyspnoea—Hydroxyurea—head and neck cancer	0.000357	0.00215	CcSEcCtD
Sunitinib—Erythema—Fluorouracil—head and neck cancer	0.000353	0.00213	CcSEcCtD
Sunitinib—Dyspepsia—Hydroxyurea—head and neck cancer	0.000353	0.00212	CcSEcCtD
Sunitinib—Decreased appetite—Hydroxyurea—head and neck cancer	0.000348	0.0021	CcSEcCtD
Sunitinib—Pancytopenia—Docetaxel—head and neck cancer	0.000348	0.00209	CcSEcCtD
Sunitinib—Abdominal pain—Vinblastine—head and neck cancer	0.000347	0.00209	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000346	0.00208	CcSEcCtD
Sunitinib—Fatigue—Hydroxyurea—head and neck cancer	0.000346	0.00208	CcSEcCtD
Sunitinib—Pain—Hydroxyurea—head and neck cancer	0.000343	0.00206	CcSEcCtD
Sunitinib—Constipation—Hydroxyurea—head and neck cancer	0.000343	0.00206	CcSEcCtD
Sunitinib—Neutropenia—Docetaxel—head and neck cancer	0.000342	0.00206	CcSEcCtD
Sunitinib—Weight decreased—Docetaxel—head and neck cancer	0.000331	0.00199	CcSEcCtD
Sunitinib—Pneumonia—Docetaxel—head and neck cancer	0.000328	0.00198	CcSEcCtD
Sunitinib—Anaemia—Fluorouracil—head and neck cancer	0.000327	0.00197	CcSEcCtD
Sunitinib—Infestation NOS—Docetaxel—head and neck cancer	0.000326	0.00196	CcSEcCtD
Sunitinib—Infestation—Docetaxel—head and neck cancer	0.000326	0.00196	CcSEcCtD
Sunitinib—Hypersensitivity—Vinblastine—head and neck cancer	0.000324	0.00195	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000324	0.00195	CcSEcCtD
Sunitinib—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000322	0.00194	CcSEcCtD
Sunitinib—Renal failure—Docetaxel—head and neck cancer	0.000321	0.00193	CcSEcCtD
Sunitinib—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00032	0.00193	CcSEcCtD
Sunitinib—Stomatitis—Docetaxel—head and neck cancer	0.000318	0.00191	CcSEcCtD
Sunitinib—Body temperature increased—Hydroxyurea—head and neck cancer	0.000317	0.00191	CcSEcCtD
Sunitinib—Leukopenia—Fluorouracil—head and neck cancer	0.000316	0.0019	CcSEcCtD
Sunitinib—Asthenia—Vinblastine—head and neck cancer	0.000315	0.0019	CcSEcCtD
Sunitinib—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000309	0.00186	CcSEcCtD
Sunitinib—MAP4K4—thyroid gland—head and neck cancer	0.000308	0.00133	CbGeAlD
Sunitinib—PRKAA1—lymphoid tissue—head and neck cancer	0.000308	0.00133	CbGeAlD
Sunitinib—Epistaxis—Docetaxel—head and neck cancer	0.000308	0.00185	CcSEcCtD
Sunitinib—AXL—trachea—head and neck cancer	0.000307	0.00133	CbGeAlD
Sunitinib—FLT1—epithelium—head and neck cancer	0.000307	0.00133	CbGeAlD
Sunitinib—Convulsion—Fluorouracil—head and neck cancer	0.000306	0.00184	CcSEcCtD
Sunitinib—SBK1—lymph node—head and neck cancer	0.000306	0.00133	CbGeAlD
Sunitinib—ITK—lymph node—head and neck cancer	0.000306	0.00133	CbGeAlD
Sunitinib—NUAK2—thyroid gland—head and neck cancer	0.000306	0.00133	CbGeAlD
Sunitinib—PTK2B—lymphoid tissue—head and neck cancer	0.000305	0.00132	CbGeAlD
Sunitinib—TAOK3—connective tissue—head and neck cancer	0.000305	0.00132	CbGeAlD
Sunitinib—DAPK3—head—head and neck cancer	0.000304	0.00132	CbGeAlD
Sunitinib—MAP3K12—thyroid gland—head and neck cancer	0.000304	0.00132	CbGeAlD
Sunitinib—FLT4—lymphoid tissue—head and neck cancer	0.000304	0.00132	CbGeAlD
Sunitinib—PDGFRA—connective tissue—head and neck cancer	0.000303	0.00131	CbGeAlD
Sunitinib—BLK—lymph node—head and neck cancer	0.000303	0.00131	CbGeAlD
Sunitinib—CLK2—head—head and neck cancer	0.000302	0.00131	CbGeAlD
Sunitinib—Myalgia—Fluorouracil—head and neck cancer	0.000301	0.00181	CcSEcCtD
Sunitinib—Chest pain—Fluorouracil—head and neck cancer	0.000301	0.00181	CcSEcCtD
Sunitinib—Diarrhoea—Vinblastine—head and neck cancer	0.000301	0.00181	CcSEcCtD
Sunitinib—RPS6KA3—thyroid gland—head and neck cancer	0.0003	0.0013	CbGeAlD
Sunitinib—PHKG1—lymph node—head and neck cancer	0.000299	0.0013	CbGeAlD
Sunitinib—DAPK1—lymph node—head and neck cancer	0.000299	0.0013	CbGeAlD
Sunitinib—KDR—saliva-secreting gland—head and neck cancer	0.000297	0.00129	CbGeAlD
Sunitinib—MAP2K5—saliva-secreting gland—head and neck cancer	0.000297	0.00129	CbGeAlD
Sunitinib—STK3—head—head and neck cancer	0.000296	0.00128	CbGeAlD
Sunitinib—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000295	0.00178	CcSEcCtD
Sunitinib—SLK—trachea—head and neck cancer	0.000295	0.00128	CbGeAlD
Sunitinib—IRAK4—lymphoid tissue—head and neck cancer	0.000295	0.00128	CbGeAlD
Sunitinib—Haemoglobin—Docetaxel—head and neck cancer	0.000295	0.00177	CcSEcCtD
Sunitinib—CSNK1A1—thyroid gland—head and neck cancer	0.000294	0.00127	CbGeAlD
Sunitinib—Haemorrhage—Docetaxel—head and neck cancer	0.000293	0.00176	CcSEcCtD
Sunitinib—Hepatitis—Docetaxel—head and neck cancer	0.000293	0.00176	CcSEcCtD
Sunitinib—ROCK1—head—head and neck cancer	0.000292	0.00127	CbGeAlD
Sunitinib—CLK1—thyroid gland—head and neck cancer	0.000292	0.00126	CbGeAlD
Sunitinib—Hypoaesthesia—Docetaxel—head and neck cancer	0.000292	0.00175	CcSEcCtD
Sunitinib—JAK2—trachea—head and neck cancer	0.000291	0.00126	CbGeAlD
Sunitinib—Dizziness—Vinblastine—head and neck cancer	0.000291	0.00175	CcSEcCtD
Sunitinib—STK11—lymph node—head and neck cancer	0.00029	0.00126	CbGeAlD
Sunitinib—BRD4—lymph node—head and neck cancer	0.00029	0.00126	CbGeAlD
Sunitinib—Urinary tract disorder—Docetaxel—head and neck cancer	0.000289	0.00174	CcSEcCtD
Sunitinib—Oedema peripheral—Docetaxel—head and neck cancer	0.000289	0.00174	CcSEcCtD
Sunitinib—Oedema—Fluorouracil—head and neck cancer	0.000288	0.00174	CcSEcCtD
Sunitinib—MAP2K2—lymphoid tissue—head and neck cancer	0.000288	0.00125	CbGeAlD
Sunitinib—Connective tissue disorder—Docetaxel—head and neck cancer	0.000288	0.00173	CcSEcCtD
Sunitinib—Asthenia—Hydroxyurea—head and neck cancer	0.000288	0.00173	CcSEcCtD
Sunitinib—Urethral disorder—Docetaxel—head and neck cancer	0.000287	0.00173	CcSEcCtD
Sunitinib—FYN—trachea—head and neck cancer	0.000287	0.00124	CbGeAlD
Sunitinib—RPS6KA1—lymph node—head and neck cancer	0.000287	0.00124	CbGeAlD
Sunitinib—RIOK1—lymph node—head and neck cancer	0.000287	0.00124	CbGeAlD
Sunitinib—Infection—Fluorouracil—head and neck cancer	0.000287	0.00172	CcSEcCtD
Sunitinib—BMP2K—thyroid gland—head and neck cancer	0.000286	0.00124	CbGeAlD
Sunitinib—CAMK2G—thyroid gland—head and neck cancer	0.000286	0.00124	CbGeAlD
Sunitinib—MAP3K2—lymphoid tissue—head and neck cancer	0.000286	0.00124	CbGeAlD
Sunitinib—DYRK1A—head—head and neck cancer	0.000285	0.00124	CbGeAlD
Sunitinib—LRRK2—thyroid gland—head and neck cancer	0.000284	0.00123	CbGeAlD
Sunitinib—Nervous system disorder—Fluorouracil—head and neck cancer	0.000283	0.0017	CcSEcCtD
Sunitinib—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000282	0.0017	CcSEcCtD
Sunitinib—MARK2—lymph node—head and neck cancer	0.000281	0.00122	CbGeAlD
Sunitinib—TNIK—lymph node—head and neck cancer	0.000281	0.00122	CbGeAlD
Sunitinib—MAP4K5—trachea—head and neck cancer	0.00028	0.00122	CbGeAlD
Sunitinib—MAP3K3—trachea—head and neck cancer	0.00028	0.00122	CbGeAlD
Sunitinib—TBK1—lymphoid tissue—head and neck cancer	0.00028	0.00122	CbGeAlD
Sunitinib—PRKAA1—thyroid gland—head and neck cancer	0.00028	0.00121	CbGeAlD
Sunitinib—Vomiting—Vinblastine—head and neck cancer	0.000279	0.00168	CcSEcCtD
Sunitinib—SGK3—lymph node—head and neck cancer	0.000279	0.00121	CbGeAlD
Sunitinib—TYK2—lymphoid tissue—head and neck cancer	0.000279	0.00121	CbGeAlD
Sunitinib—MERTK—head—head and neck cancer	0.000278	0.00121	CbGeAlD
Sunitinib—Erythema multiforme—Docetaxel—head and neck cancer	0.000277	0.00167	CcSEcCtD
Sunitinib—PTK2B—thyroid gland—head and neck cancer	0.000277	0.0012	CbGeAlD
Sunitinib—ICK—lymph node—head and neck cancer	0.000276	0.0012	CbGeAlD
Sunitinib—FLT4—thyroid gland—head and neck cancer	0.000276	0.0012	CbGeAlD
Sunitinib—Headache—Vinblastine—head and neck cancer	0.000275	0.00166	CcSEcCtD
Sunitinib—Anorexia—Fluorouracil—head and neck cancer	0.000275	0.00165	CcSEcCtD
Sunitinib—KIT—parotid gland—head and neck cancer	0.000275	0.00119	CbGeAlD
Sunitinib—Diarrhoea—Hydroxyurea—head and neck cancer	0.000274	0.00165	CcSEcCtD
Sunitinib—Eye disorder—Docetaxel—head and neck cancer	0.000274	0.00165	CcSEcCtD
Sunitinib—MAP4K4—head—head and neck cancer	0.000273	0.00118	CbGeAlD
Sunitinib—KDR—connective tissue—head and neck cancer	0.000273	0.00118	CbGeAlD
Sunitinib—CSNK1E—thyroid gland—head and neck cancer	0.000272	0.00118	CbGeAlD
Sunitinib—FGFR1—thyroid gland—head and neck cancer	0.000272	0.00118	CbGeAlD
Sunitinib—Cardiac disorder—Docetaxel—head and neck cancer	0.000272	0.00164	CcSEcCtD
Sunitinib—Flushing—Docetaxel—head and neck cancer	0.000272	0.00164	CcSEcCtD
Sunitinib—FLT1—trachea—head and neck cancer	0.000271	0.00117	CbGeAlD
Sunitinib—RPS6KB1—lymphoid tissue—head and neck cancer	0.00027	0.00117	CbGeAlD
Sunitinib—MAP3K12—head—head and neck cancer	0.000269	0.00117	CbGeAlD
Sunitinib—PDGFRB—parotid gland—head and neck cancer	0.000269	0.00116	CbGeAlD
Sunitinib—RET—lymphoid tissue—head and neck cancer	0.000268	0.00116	CbGeAlD
Sunitinib—FGR—lymphoid tissue—head and neck cancer	0.000268	0.00116	CbGeAlD
Sunitinib—EPHB6—trachea—head and neck cancer	0.000268	0.00116	CbGeAlD
Sunitinib—IRAK4—thyroid gland—head and neck cancer	0.000268	0.00116	CbGeAlD
Sunitinib—AXL—lymphoid tissue—head and neck cancer	0.000267	0.00116	CbGeAlD
Sunitinib—CHEK2—lymph node—head and neck cancer	0.000267	0.00116	CbGeAlD
Sunitinib—NUAK1—lymph node—head and neck cancer	0.000267	0.00116	CbGeAlD
Sunitinib—CSF1R—connective tissue—head and neck cancer	0.000266	0.00115	CbGeAlD
Sunitinib—Angiopathy—Docetaxel—head and neck cancer	0.000266	0.0016	CcSEcCtD
Sunitinib—RPS6KA3—head—head and neck cancer	0.000266	0.00115	CbGeAlD
Sunitinib—Dizziness—Hydroxyurea—head and neck cancer	0.000265	0.00159	CcSEcCtD
Sunitinib—Immune system disorder—Docetaxel—head and neck cancer	0.000265	0.00159	CcSEcCtD
Sunitinib—INSR—lymph node—head and neck cancer	0.000264	0.00115	CbGeAlD
Sunitinib—SNRK—lymph node—head and neck cancer	0.000264	0.00115	CbGeAlD
Sunitinib—OXSR1—lymph node—head and neck cancer	0.000264	0.00115	CbGeAlD
Sunitinib—Mediastinal disorder—Docetaxel—head and neck cancer	0.000264	0.00159	CcSEcCtD
Sunitinib—MAP2K1—head—head and neck cancer	0.000264	0.00114	CbGeAlD
Sunitinib—KIT—saliva-secreting gland—head and neck cancer	0.000263	0.00114	CbGeAlD
Sunitinib—Chills—Docetaxel—head and neck cancer	0.000263	0.00158	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000263	0.00158	CcSEcCtD
Sunitinib—MAP2K2—thyroid gland—head and neck cancer	0.000262	0.00113	CbGeAlD
Sunitinib—ULK3—thyroid gland—head and neck cancer	0.000262	0.00113	CbGeAlD
Sunitinib—Arrhythmia—Docetaxel—head and neck cancer	0.000262	0.00157	CcSEcCtD
Sunitinib—Nausea—Vinblastine—head and neck cancer	0.000261	0.00157	CcSEcCtD
Sunitinib—Insomnia—Fluorouracil—head and neck cancer	0.000261	0.00157	CcSEcCtD
Sunitinib—CSNK1A1—head—head and neck cancer	0.000261	0.00113	CbGeAlD
Sunitinib—RPS6KA2—lymph node—head and neck cancer	0.00026	0.00113	CbGeAlD
Sunitinib—STK38—lymph node—head and neck cancer	0.00026	0.00113	CbGeAlD
Sunitinib—MAP3K2—thyroid gland—head and neck cancer	0.00026	0.00113	CbGeAlD
Sunitinib—KDR—epithelium—head and neck cancer	0.000259	0.00112	CbGeAlD
Sunitinib—Paraesthesia—Fluorouracil—head and neck cancer	0.000259	0.00156	CcSEcCtD
Sunitinib—YES1—trachea—head and neck cancer	0.000259	0.00112	CbGeAlD
Sunitinib—Alopecia—Docetaxel—head and neck cancer	0.000259	0.00156	CcSEcCtD
Sunitinib—CLK1—head—head and neck cancer	0.000259	0.00112	CbGeAlD
Sunitinib—AURKC—lymph node—head and neck cancer	0.000258	0.00112	CbGeAlD
Sunitinib—MAP3K7—thyroid gland—head and neck cancer	0.000258	0.00112	CbGeAlD
Sunitinib—Dyspnoea—Fluorouracil—head and neck cancer	0.000257	0.00155	CcSEcCtD
Sunitinib—PDGFRB—saliva-secreting gland—head and neck cancer	0.000257	0.00111	CbGeAlD
Sunitinib—Mental disorder—Docetaxel—head and neck cancer	0.000257	0.00154	CcSEcCtD
Sunitinib—CSNK1G2—lymph node—head and neck cancer	0.000256	0.00111	CbGeAlD
Sunitinib—PKN1—lymph node—head and neck cancer	0.000256	0.00111	CbGeAlD
Sunitinib—TAOK3—trachea—head and neck cancer	0.000256	0.00111	CbGeAlD
Sunitinib—Malnutrition—Docetaxel—head and neck cancer	0.000255	0.00153	CcSEcCtD
Sunitinib—Erythema—Docetaxel—head and neck cancer	0.000255	0.00153	CcSEcCtD
Sunitinib—Vomiting—Hydroxyurea—head and neck cancer	0.000255	0.00153	CcSEcCtD
Sunitinib—TBK1—thyroid gland—head and neck cancer	0.000255	0.0011	CbGeAlD
Sunitinib—CAMK2G—head—head and neck cancer	0.000254	0.0011	CbGeAlD
Sunitinib—BMP2K—head—head and neck cancer	0.000254	0.0011	CbGeAlD
Sunitinib—PDGFRA—trachea—head and neck cancer	0.000254	0.0011	CbGeAlD
Sunitinib—Dyspepsia—Fluorouracil—head and neck cancer	0.000254	0.00153	CcSEcCtD
Sunitinib—JAK2—lymphoid tissue—head and neck cancer	0.000253	0.0011	CbGeAlD
Sunitinib—TYK2—thyroid gland—head and neck cancer	0.000253	0.0011	CbGeAlD
Sunitinib—Rash—Hydroxyurea—head and neck cancer	0.000253	0.00152	CcSEcCtD
Sunitinib—PRPF4—lymph node—head and neck cancer	0.000253	0.00109	CbGeAlD
Sunitinib—Dermatitis—Hydroxyurea—head and neck cancer	0.000252	0.00152	CcSEcCtD
Sunitinib—LRRK2—head—head and neck cancer	0.000252	0.00109	CbGeAlD
Sunitinib—Headache—Hydroxyurea—head and neck cancer	0.000251	0.00151	CcSEcCtD
Sunitinib—Decreased appetite—Fluorouracil—head and neck cancer	0.000251	0.00151	CcSEcCtD
Sunitinib—FYN—lymphoid tissue—head and neck cancer	0.00025	0.00108	CbGeAlD
Sunitinib—Dysgeusia—Docetaxel—head and neck cancer	0.00025	0.0015	CcSEcCtD
Sunitinib—IRAK1—thyroid gland—head and neck cancer	0.00025	0.00108	CbGeAlD
Sunitinib—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000249	0.0015	CcSEcCtD
Sunitinib—PRPF4B—lymph node—head and neck cancer	0.000249	0.00108	CbGeAlD
Sunitinib—PRKAA1—head—head and neck cancer	0.000248	0.00108	CbGeAlD
Sunitinib—Back pain—Docetaxel—head and neck cancer	0.000247	0.00148	CcSEcCtD
Sunitinib—Pain—Fluorouracil—head and neck cancer	0.000247	0.00148	CcSEcCtD
Sunitinib—STK39—lymph node—head and neck cancer	0.000246	0.00106	CbGeAlD
Sunitinib—PTK2B—head—head and neck cancer	0.000245	0.00106	CbGeAlD
Sunitinib—Muscle spasms—Docetaxel—head and neck cancer	0.000245	0.00148	CcSEcCtD
Sunitinib—RPS6KB1—thyroid gland—head and neck cancer	0.000245	0.00106	CbGeAlD
Sunitinib—FLT4—head—head and neck cancer	0.000245	0.00106	CbGeAlD
Sunitinib—MAP4K5—lymphoid tissue—head and neck cancer	0.000244	0.00106	CbGeAlD
Sunitinib—FGR—thyroid gland—head and neck cancer	0.000244	0.00106	CbGeAlD
Sunitinib—RET—thyroid gland—head and neck cancer	0.000244	0.00106	CbGeAlD
Sunitinib—AXL—thyroid gland—head and neck cancer	0.000243	0.00105	CbGeAlD
Sunitinib—CSNK2A1—lymph node—head and neck cancer	0.000242	0.00105	CbGeAlD
Sunitinib—KIT—connective tissue—head and neck cancer	0.000242	0.00105	CbGeAlD
Sunitinib—CSNK1E—head—head and neck cancer	0.000241	0.00105	CbGeAlD
Sunitinib—MYLK—lymph node—head and neck cancer	0.000239	0.00104	CbGeAlD
Sunitinib—Nausea—Hydroxyurea—head and neck cancer	0.000238	0.00143	CcSEcCtD
Sunitinib—IRAK4—head—head and neck cancer	0.000238	0.00103	CbGeAlD
Sunitinib—PDGFRB—connective tissue—head and neck cancer	0.000236	0.00102	CbGeAlD
Sunitinib—PLK4—lymph node—head and neck cancer	0.000236	0.00102	CbGeAlD
Sunitinib—FLT1—lymphoid tissue—head and neck cancer	0.000236	0.00102	CbGeAlD
Sunitinib—Anaemia—Docetaxel—head and neck cancer	0.000236	0.00142	CcSEcCtD
Sunitinib—STK4—lymph node—head and neck cancer	0.000235	0.00102	CbGeAlD
Sunitinib—SLK—thyroid gland—head and neck cancer	0.000233	0.00101	CbGeAlD
Sunitinib—ULK3—head—head and neck cancer	0.000232	0.00101	CbGeAlD
Sunitinib—MAP2K2—head—head and neck cancer	0.000232	0.00101	CbGeAlD
Sunitinib—FGFR2—thyroid gland—head and neck cancer	0.000231	0.001	CbGeAlD
Sunitinib—MAP3K2—head—head and neck cancer	0.000231	0.001	CbGeAlD
Sunitinib—PHKG2—lymph node—head and neck cancer	0.000231	0.000999	CbGeAlD
Sunitinib—JAK2—thyroid gland—head and neck cancer	0.00023	0.000997	CbGeAlD
Sunitinib—KIT—epithelium—head and neck cancer	0.00023	0.000995	CbGeAlD
Sunitinib—STK24—lymph node—head and neck cancer	0.000229	0.000994	CbGeAlD
Sunitinib—MAP2K5—trachea—head and neck cancer	0.000229	0.000993	CbGeAlD
Sunitinib—KDR—trachea—head and neck cancer	0.000229	0.000993	CbGeAlD
Sunitinib—Leukopenia—Docetaxel—head and neck cancer	0.000228	0.00137	CcSEcCtD
Sunitinib—Body temperature increased—Fluorouracil—head and neck cancer	0.000228	0.00137	CcSEcCtD
Sunitinib—FYN—thyroid gland—head and neck cancer	0.000227	0.000984	CbGeAlD
Sunitinib—DAPK2—lymph node—head and neck cancer	0.000227	0.000982	CbGeAlD
Sunitinib—TBK1—head—head and neck cancer	0.000226	0.000979	CbGeAlD
Sunitinib—YES1—lymphoid tissue—head and neck cancer	0.000226	0.000977	CbGeAlD
Sunitinib—TYK2—head—head and neck cancer	0.000224	0.000972	CbGeAlD
Sunitinib—PDGFRB—epithelium—head and neck cancer	0.000224	0.000972	CbGeAlD
Sunitinib—CSF1R—trachea—head and neck cancer	0.000224	0.000969	CbGeAlD
Sunitinib—STK10—lymphoid tissue—head and neck cancer	0.000224	0.000969	CbGeAlD
Sunitinib—STK16—lymph node—head and neck cancer	0.000223	0.000966	CbGeAlD
Sunitinib—TAOK3—lymphoid tissue—head and neck cancer	0.000223	0.000965	CbGeAlD
Sunitinib—Cough—Docetaxel—head and neck cancer	0.000223	0.00134	CcSEcCtD
Sunitinib—HIPK2—lymph node—head and neck cancer	0.000222	0.000961	CbGeAlD
Sunitinib—HIPK3—lymph node—head and neck cancer	0.000222	0.000961	CbGeAlD
Sunitinib—ALK—lymph node—head and neck cancer	0.000222	0.000961	CbGeAlD
Sunitinib—MAP3K3—thyroid gland—head and neck cancer	0.000222	0.000961	CbGeAlD
Sunitinib—MAP4K5—thyroid gland—head and neck cancer	0.000222	0.000961	CbGeAlD
Sunitinib—PDGFRA—lymphoid tissue—head and neck cancer	0.000221	0.000959	CbGeAlD
Sunitinib—Convulsion—Docetaxel—head and neck cancer	0.000221	0.00133	CcSEcCtD
Sunitinib—Hypertension—Docetaxel—head and neck cancer	0.00022	0.00133	CcSEcCtD
Sunitinib—RIOK2—lymph node—head and neck cancer	0.00022	0.000951	CbGeAlD
Sunitinib—TNK1—lymph node—head and neck cancer	0.00022	0.000951	CbGeAlD
Sunitinib—MAP4K1—lymph node—head and neck cancer	0.000217	0.000942	CbGeAlD
Sunitinib—RPS6KB1—head—head and neck cancer	0.000217	0.000942	CbGeAlD
Sunitinib—Chest pain—Docetaxel—head and neck cancer	0.000217	0.00131	CcSEcCtD
Sunitinib—Arthralgia—Docetaxel—head and neck cancer	0.000217	0.00131	CcSEcCtD
Sunitinib—Myalgia—Docetaxel—head and neck cancer	0.000217	0.00131	CcSEcCtD
Sunitinib—RET—head—head and neck cancer	0.000216	0.000936	CbGeAlD
Sunitinib—FGR—head—head and neck cancer	0.000216	0.000936	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000216	0.0013	CcSEcCtD
Sunitinib—AXL—head—head and neck cancer	0.000215	0.000932	CbGeAlD
Sunitinib—FLT1—thyroid gland—head and neck cancer	0.000214	0.000929	CbGeAlD
Sunitinib—DAPK3—lymph node—head and neck cancer	0.000213	0.000924	CbGeAlD
Sunitinib—Hypersensitivity—Fluorouracil—head and neck cancer	0.000213	0.00128	CcSEcCtD
Sunitinib—Dry mouth—Docetaxel—head and neck cancer	0.000212	0.00128	CcSEcCtD
Sunitinib—EPHB6—thyroid gland—head and neck cancer	0.000212	0.000919	CbGeAlD
Sunitinib—CLK2—lymph node—head and neck cancer	0.000211	0.000915	CbGeAlD
Sunitinib—MAP4K2—lymph node—head and neck cancer	0.00021	0.000911	CbGeAlD
Sunitinib—Oedema—Docetaxel—head and neck cancer	0.000208	0.00125	CcSEcCtD
Sunitinib—STK3—lymph node—head and neck cancer	0.000207	0.000898	CbGeAlD
Sunitinib—Infection—Docetaxel—head and neck cancer	0.000207	0.00124	CcSEcCtD
Sunitinib—FGFR2—head—head and neck cancer	0.000205	0.000889	CbGeAlD
Sunitinib—YES1—thyroid gland—head and neck cancer	0.000205	0.000888	CbGeAlD
Sunitinib—Shock—Docetaxel—head and neck cancer	0.000205	0.00123	CcSEcCtD
Sunitinib—JAK2—head—head and neck cancer	0.000204	0.000885	CbGeAlD
Sunitinib—Nervous system disorder—Docetaxel—head and neck cancer	0.000204	0.00123	CcSEcCtD
Sunitinib—Pruritus—Fluorouracil—head and neck cancer	0.000204	0.00123	CcSEcCtD
Sunitinib—Thrombocytopenia—Docetaxel—head and neck cancer	0.000204	0.00123	CcSEcCtD
Sunitinib—KIT—trachea—head and neck cancer	0.000203	0.00088	CbGeAlD
Sunitinib—STK10—thyroid gland—head and neck cancer	0.000203	0.00088	CbGeAlD
Sunitinib—TAOK3—thyroid gland—head and neck cancer	0.000202	0.000876	CbGeAlD
Sunitinib—Skin disorder—Docetaxel—head and neck cancer	0.000202	0.00122	CcSEcCtD
Sunitinib—FYN—head—head and neck cancer	0.000201	0.000873	CbGeAlD
Sunitinib—PDGFRA—thyroid gland—head and neck cancer	0.000201	0.000871	CbGeAlD
Sunitinib—KDR—lymphoid tissue—head and neck cancer	0.0002	0.000865	CbGeAlD
Sunitinib—DYRK1A—lymph node—head and neck cancer	0.0002	0.000865	CbGeAlD
Sunitinib—Anorexia—Docetaxel—head and neck cancer	0.000198	0.00119	CcSEcCtD
Sunitinib—PDGFRB—trachea—head and neck cancer	0.000198	0.00086	CbGeAlD
Sunitinib—Diarrhoea—Fluorouracil—head and neck cancer	0.000197	0.00119	CcSEcCtD
Sunitinib—MAP3K3—head—head and neck cancer	0.000197	0.000853	CbGeAlD
Sunitinib—MAP4K5—head—head and neck cancer	0.000197	0.000853	CbGeAlD
Sunitinib—MERTK—lymph node—head and neck cancer	0.000195	0.000845	CbGeAlD
Sunitinib—CSF1R—lymphoid tissue—head and neck cancer	0.000195	0.000844	CbGeAlD
Sunitinib—MAP4K4—lymph node—head and neck cancer	0.000191	0.000829	CbGeAlD
Sunitinib—Dizziness—Fluorouracil—head and neck cancer	0.000191	0.00115	CcSEcCtD
Sunitinib—FLT1—head—head and neck cancer	0.00019	0.000824	CbGeAlD
Sunitinib—NUAK2—lymph node—head and neck cancer	0.00019	0.000823	CbGeAlD
Sunitinib—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00019	0.00114	CcSEcCtD
Sunitinib—FLT3—lymph node—head and neck cancer	0.000189	0.000817	CbGeAlD
Sunitinib—MAP3K12—lymph node—head and neck cancer	0.000189	0.000817	CbGeAlD
Sunitinib—Insomnia—Docetaxel—head and neck cancer	0.000188	0.00113	CcSEcCtD
Sunitinib—EPHB6—head—head and neck cancer	0.000188	0.000815	CbGeAlD
Sunitinib—Paraesthesia—Docetaxel—head and neck cancer	0.000187	0.00112	CcSEcCtD
Sunitinib—RPS6KA3—lymph node—head and neck cancer	0.000186	0.000806	CbGeAlD
Sunitinib—Dyspnoea—Docetaxel—head and neck cancer	0.000186	0.00112	CcSEcCtD
Sunitinib—MAP2K1—lymph node—head and neck cancer	0.000185	0.000801	CbGeAlD
Sunitinib—Vomiting—Fluorouracil—head and neck cancer	0.000183	0.0011	CcSEcCtD
Sunitinib—Dyspepsia—Docetaxel—head and neck cancer	0.000183	0.0011	CcSEcCtD
Sunitinib—CSNK1A1—lymph node—head and neck cancer	0.000182	0.00079	CbGeAlD
Sunitinib—Rash—Fluorouracil—head and neck cancer	0.000182	0.00109	CcSEcCtD
Sunitinib—YES1—head—head and neck cancer	0.000182	0.000788	CbGeAlD
Sunitinib—Dermatitis—Fluorouracil—head and neck cancer	0.000182	0.00109	CcSEcCtD
Sunitinib—KDR—thyroid gland—head and neck cancer	0.000181	0.000786	CbGeAlD
Sunitinib—MAP2K5—thyroid gland—head and neck cancer	0.000181	0.000786	CbGeAlD
Sunitinib—CLK1—lymph node—head and neck cancer	0.000181	0.000785	CbGeAlD
Sunitinib—Decreased appetite—Docetaxel—head and neck cancer	0.000181	0.00109	CcSEcCtD
Sunitinib—Headache—Fluorouracil—head and neck cancer	0.000181	0.00109	CcSEcCtD
Sunitinib—STK10—head—head and neck cancer	0.00018	0.00078	CbGeAlD
Sunitinib—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00018	0.00108	CcSEcCtD
Sunitinib—Fatigue—Docetaxel—head and neck cancer	0.000179	0.00108	CcSEcCtD
Sunitinib—TAOK3—head—head and neck cancer	0.000179	0.000777	CbGeAlD
Sunitinib—PDGFRA—head—head and neck cancer	0.000178	0.000773	CbGeAlD
Sunitinib—Constipation—Docetaxel—head and neck cancer	0.000178	0.00107	CcSEcCtD
Sunitinib—Pain—Docetaxel—head and neck cancer	0.000178	0.00107	CcSEcCtD
Sunitinib—CAMK2G—lymph node—head and neck cancer	0.000178	0.000771	CbGeAlD
Sunitinib—BMP2K—lymph node—head and neck cancer	0.000178	0.000771	CbGeAlD
Sunitinib—CSF1R—thyroid gland—head and neck cancer	0.000177	0.000767	CbGeAlD
Sunitinib—KIT—lymphoid tissue—head and neck cancer	0.000177	0.000766	CbGeAlD
Sunitinib—LRRK2—lymph node—head and neck cancer	0.000176	0.000764	CbGeAlD
Sunitinib—PRKAA1—lymph node—head and neck cancer	0.000174	0.000753	CbGeAlD
Sunitinib—PDGFRB—lymphoid tissue—head and neck cancer	0.000173	0.000749	CbGeAlD
Sunitinib—PTK2B—lymph node—head and neck cancer	0.000172	0.000745	CbGeAlD
Sunitinib—FLT4—lymph node—head and neck cancer	0.000171	0.000742	CbGeAlD
Sunitinib—Nausea—Fluorouracil—head and neck cancer	0.000171	0.00103	CcSEcCtD
Sunitinib—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00017	0.00102	CcSEcCtD
Sunitinib—CSNK1E—lymph node—head and neck cancer	0.000169	0.000732	CbGeAlD
Sunitinib—FGFR1—lymph node—head and neck cancer	0.000169	0.000732	CbGeAlD
Sunitinib—IRAK4—lymph node—head and neck cancer	0.000166	0.000721	CbGeAlD
Sunitinib—Abdominal pain—Docetaxel—head and neck cancer	0.000165	0.00099	CcSEcCtD
Sunitinib—Body temperature increased—Docetaxel—head and neck cancer	0.000165	0.00099	CcSEcCtD
Sunitinib—MAP2K2—lymph node—head and neck cancer	0.000163	0.000705	CbGeAlD
Sunitinib—ULK3—lymph node—head and neck cancer	0.000163	0.000705	CbGeAlD
Sunitinib—MAP3K2—lymph node—head and neck cancer	0.000162	0.0007	CbGeAlD
Sunitinib—KDR—head—head and neck cancer	0.000161	0.000697	CbGeAlD
Sunitinib—MAP2K5—head—head and neck cancer	0.000161	0.000697	CbGeAlD
Sunitinib—KIT—thyroid gland—head and neck cancer	0.000161	0.000696	CbGeAlD
Sunitinib—MAP3K7—lymph node—head and neck cancer	0.00016	0.000693	CbGeAlD
Sunitinib—TBK1—lymph node—head and neck cancer	0.000158	0.000686	CbGeAlD
Sunitinib—TYK2—lymph node—head and neck cancer	0.000157	0.000681	CbGeAlD
Sunitinib—CSF1R—head—head and neck cancer	0.000157	0.00068	CbGeAlD
Sunitinib—PDGFRB—thyroid gland—head and neck cancer	0.000157	0.00068	CbGeAlD
Sunitinib—IRAK1—lymph node—head and neck cancer	0.000155	0.000672	CbGeAlD
Sunitinib—Hypersensitivity—Docetaxel—head and neck cancer	0.000153	0.000923	CcSEcCtD
Sunitinib—RPS6KB1—lymph node—head and neck cancer	0.000152	0.000659	CbGeAlD
Sunitinib—RET—lymph node—head and neck cancer	0.000151	0.000655	CbGeAlD
Sunitinib—FGR—lymph node—head and neck cancer	0.000151	0.000655	CbGeAlD
Sunitinib—ABCG2—parotid gland—head and neck cancer	0.000151	0.000654	CbGeAlD
Sunitinib—AXL—lymph node—head and neck cancer	0.000151	0.000653	CbGeAlD
Sunitinib—Asthenia—Docetaxel—head and neck cancer	0.000149	0.000899	CcSEcCtD
Sunitinib—Pruritus—Docetaxel—head and neck cancer	0.000147	0.000886	CcSEcCtD
Sunitinib—SLK—lymph node—head and neck cancer	0.000145	0.000628	CbGeAlD
Sunitinib—ABCG2—saliva-secreting gland—head and neck cancer	0.000145	0.000626	CbGeAlD
Sunitinib—JAK2—lymph node—head and neck cancer	0.000143	0.000619	CbGeAlD
Sunitinib—KIT—head—head and neck cancer	0.000143	0.000618	CbGeAlD
Sunitinib—Diarrhoea—Docetaxel—head and neck cancer	0.000142	0.000857	CcSEcCtD
Sunitinib—FYN—lymph node—head and neck cancer	0.000141	0.000611	CbGeAlD
Sunitinib—PDGFRB—head—head and neck cancer	0.000139	0.000603	CbGeAlD
Sunitinib—MAP4K5—lymph node—head and neck cancer	0.000138	0.000597	CbGeAlD
Sunitinib—MAP3K3—lymph node—head and neck cancer	0.000138	0.000597	CbGeAlD
Sunitinib—Dizziness—Docetaxel—head and neck cancer	0.000138	0.000828	CcSEcCtD
Sunitinib—FLT1—lymph node—head and neck cancer	0.000133	0.000577	CbGeAlD
Sunitinib—Vomiting—Docetaxel—head and neck cancer	0.000132	0.000796	CcSEcCtD
Sunitinib—EPHB6—lymph node—head and neck cancer	0.000132	0.000571	CbGeAlD
Sunitinib—Rash—Docetaxel—head and neck cancer	0.000131	0.00079	CcSEcCtD
Sunitinib—Dermatitis—Docetaxel—head and neck cancer	0.000131	0.000789	CcSEcCtD
Sunitinib—Headache—Docetaxel—head and neck cancer	0.00013	0.000785	CcSEcCtD
Sunitinib—YES1—lymph node—head and neck cancer	0.000127	0.000551	CbGeAlD
Sunitinib—STK10—lymph node—head and neck cancer	0.000126	0.000546	CbGeAlD
Sunitinib—TAOK3—lymph node—head and neck cancer	0.000126	0.000544	CbGeAlD
Sunitinib—ABCC4—thyroid gland—head and neck cancer	0.000125	0.000541	CbGeAlD
Sunitinib—PDGFRA—lymph node—head and neck cancer	0.000125	0.000541	CbGeAlD
Sunitinib—Nausea—Docetaxel—head and neck cancer	0.000124	0.000744	CcSEcCtD
Sunitinib—KDR—lymph node—head and neck cancer	0.000113	0.000488	CbGeAlD
Sunitinib—MAP2K5—lymph node—head and neck cancer	0.000113	0.000488	CbGeAlD
Sunitinib—ABCC4—head—head and neck cancer	0.000111	0.00048	CbGeAlD
Sunitinib—CSF1R—lymph node—head and neck cancer	0.00011	0.000476	CbGeAlD
Sunitinib—KIT—lymph node—head and neck cancer	9.98e-05	0.000432	CbGeAlD
Sunitinib—PDGFRB—lymph node—head and neck cancer	9.75e-05	0.000422	CbGeAlD
Sunitinib—ABCG2—thyroid gland—head and neck cancer	8.82e-05	0.000382	CbGeAlD
Sunitinib—KCNH2—head—head and neck cancer	8.8e-05	0.000381	CbGeAlD
Sunitinib—ABCC4—lymph node—head and neck cancer	7.76e-05	0.000336	CbGeAlD
Sunitinib—ABCC2—lymph node—head and neck cancer	7.51e-05	0.000326	CbGeAlD
Sunitinib—ABCB1—epithelium—head and neck cancer	6.22e-05	0.000269	CbGeAlD
Sunitinib—KCNH2—lymph node—head and neck cancer	6.16e-05	0.000267	CbGeAlD
Sunitinib—ABCB1—trachea—head and neck cancer	5.5e-05	0.000238	CbGeAlD
Sunitinib—ABCG2—lymph node—head and neck cancer	5.48e-05	0.000237	CbGeAlD
Sunitinib—ABCB1—lymphoid tissue—head and neck cancer	4.79e-05	0.000207	CbGeAlD
Sunitinib—ABCB1—thyroid gland—head and neck cancer	4.35e-05	0.000188	CbGeAlD
Sunitinib—ABCB1—head—head and neck cancer	3.86e-05	0.000167	CbGeAlD
Sunitinib—ABCB1—lymph node—head and neck cancer	2.7e-05	0.000117	CbGeAlD
Sunitinib—NTRK1—Signaling Pathways—PIK3CA—head and neck cancer	2.75e-06	7.71e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—HRAS—head and neck cancer	2.74e-06	7.7e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—head and neck cancer	2.74e-06	7.68e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—HRAS—head and neck cancer	2.74e-06	7.67e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MAPK3—head and neck cancer	2.73e-06	7.66e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PIK3CA—head and neck cancer	2.73e-06	7.66e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—HRAS—head and neck cancer	2.73e-06	7.65e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—MAPK1—head and neck cancer	2.72e-06	7.64e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—EGFR—head and neck cancer	2.72e-06	7.64e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—DPYD—head and neck cancer	2.72e-06	7.64e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PIK3CA—head and neck cancer	2.72e-06	7.64e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—PIK3CA—head and neck cancer	2.72e-06	7.64e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—MAPK3—head and neck cancer	2.72e-06	7.64e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—STAT3—head and neck cancer	2.71e-06	7.61e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—MAPK1—head and neck cancer	2.71e-06	7.6e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PTEN—head and neck cancer	2.71e-06	7.6e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EGFR—head and neck cancer	2.71e-06	7.6e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—HRAS—head and neck cancer	2.71e-06	7.6e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AKT1—head and neck cancer	2.7e-06	7.58e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PTEN—head and neck cancer	2.7e-06	7.58e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—head and neck cancer	2.68e-06	7.51e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—PIK3CA—head and neck cancer	2.67e-06	7.48e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—PIK3CA—head and neck cancer	2.67e-06	7.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—PIK3CA—head and neck cancer	2.66e-06	7.47e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—HRAS—head and neck cancer	2.66e-06	7.46e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—head and neck cancer	2.66e-06	7.46e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—head and neck cancer	2.66e-06	7.46e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—HRAS—head and neck cancer	2.66e-06	7.45e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—PIK3CA—head and neck cancer	2.66e-06	7.45e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL2—head and neck cancer	2.65e-06	7.44e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—STAT3—head and neck cancer	2.63e-06	7.38e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—head and neck cancer	2.63e-06	7.37e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—head and neck cancer	2.62e-06	7.36e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—STAT3—head and neck cancer	2.6e-06	7.29e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MAPK1—head and neck cancer	2.6e-06	7.29e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EGFR—head and neck cancer	2.6e-06	7.29e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—PIK3CA—head and neck cancer	2.6e-06	7.29e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—head and neck cancer	2.6e-06	7.28e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—head and neck cancer	2.59e-06	7.27e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MAPK3—head and neck cancer	2.59e-06	7.27e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—MAPK1—head and neck cancer	2.59e-06	7.27e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—EGFR—head and neck cancer	2.59e-06	7.26e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL2—head and neck cancer	2.59e-06	7.26e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCND1—head and neck cancer	2.59e-06	7.25e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—head and neck cancer	2.58e-06	7.25e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—YAP1—head and neck cancer	2.58e-06	7.25e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—HRAS—head and neck cancer	2.58e-06	7.23e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—head and neck cancer	2.58e-06	7.23e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—head and neck cancer	2.58e-06	7.23e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—head and neck cancer	2.58e-06	7.23e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—head and neck cancer	2.58e-06	7.23e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—head and neck cancer	2.57e-06	7.22e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—head and neck cancer	2.56e-06	7.18e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—PIK3CA—head and neck cancer	2.56e-06	7.18e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—HRAS—head and neck cancer	2.56e-06	7.18e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—STAT3—head and neck cancer	2.55e-06	7.16e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—STAT3—head and neck cancer	2.55e-06	7.16e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—PIK3CA—head and neck cancer	2.55e-06	7.14e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—head and neck cancer	2.55e-06	7.14e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—head and neck cancer	2.55e-06	7.14e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—HRAS—head and neck cancer	2.54e-06	7.13e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—HRAS—head and neck cancer	2.53e-06	7.08e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCND1—head and neck cancer	2.52e-06	7.08e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—HRAS—head and neck cancer	2.52e-06	7.07e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HRAS—head and neck cancer	2.52e-06	7.07e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TYMS—head and neck cancer	2.52e-06	7.06e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAPK3—head and neck cancer	2.52e-06	7.06e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PIK3CA—head and neck cancer	2.51e-06	7.05e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—head and neck cancer	2.51e-06	7.05e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PTEN—head and neck cancer	2.5e-06	7e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL2—head and neck cancer	2.49e-06	7e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTM1—head and neck cancer	2.49e-06	6.98e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAPK3—head and neck cancer	2.48e-06	6.97e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL2—head and neck cancer	2.48e-06	6.96e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—HRAS—head and neck cancer	2.47e-06	6.92e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—HRAS—head and neck cancer	2.47e-06	6.92e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MAPK1—head and neck cancer	2.47e-06	6.91e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—HRAS—head and neck cancer	2.46e-06	6.91e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EGFR—head and neck cancer	2.46e-06	6.91e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HRAS—head and neck cancer	2.46e-06	6.89e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PIK3CA—head and neck cancer	2.45e-06	6.88e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—head and neck cancer	2.45e-06	6.87e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—head and neck cancer	2.44e-06	6.85e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAPK3—head and neck cancer	2.44e-06	6.84e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAPK3—head and neck cancer	2.44e-06	6.84e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PTEN—head and neck cancer	2.43e-06	6.83e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—PIK3CA—head and neck cancer	2.43e-06	6.83e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—head and neck cancer	2.43e-06	6.83e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCND1—head and neck cancer	2.43e-06	6.82e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—STAT3—head and neck cancer	2.42e-06	6.8e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—head and neck cancer	2.42e-06	6.8e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCND1—head and neck cancer	2.42e-06	6.78e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—STAT3—head and neck cancer	2.42e-06	6.78e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—head and neck cancer	2.42e-06	6.77e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—head and neck cancer	2.41e-06	6.76e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—HRAS—head and neck cancer	2.4e-06	6.74e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—head and neck cancer	2.4e-06	6.72e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAPK1—head and neck cancer	2.39e-06	6.71e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EGFR—head and neck cancer	2.39e-06	6.71e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—head and neck cancer	2.39e-06	6.71e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GPX1—head and neck cancer	2.38e-06	6.69e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—head and neck cancer	2.37e-06	6.65e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—HRAS—head and neck cancer	2.37e-06	6.65e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—PIK3CA—head and neck cancer	2.36e-06	6.63e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAPK1—head and neck cancer	2.36e-06	6.63e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EGFR—head and neck cancer	2.36e-06	6.63e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP1A1—head and neck cancer	2.36e-06	6.62e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HRAS—head and neck cancer	2.36e-06	6.61e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PIK3CA—head and neck cancer	2.35e-06	6.6e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—head and neck cancer	2.35e-06	6.59e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PTEN—head and neck cancer	2.35e-06	6.58e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—head and neck cancer	2.35e-06	6.58e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PTEN—head and neck cancer	2.33e-06	6.55e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—HRAS—head and neck cancer	2.33e-06	6.52e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAPK1—head and neck cancer	2.32e-06	6.51e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAPK1—head and neck cancer	2.32e-06	6.51e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EGFR—head and neck cancer	2.32e-06	6.51e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EGFR—head and neck cancer	2.32e-06	6.51e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK3—head and neck cancer	2.32e-06	6.49e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCND1—head and neck cancer	2.31e-06	6.48e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK3—head and neck cancer	2.31e-06	6.48e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—head and neck cancer	2.28e-06	6.39e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—HRAS—head and neck cancer	2.27e-06	6.37e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTEN—head and neck cancer	2.26e-06	6.35e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—head and neck cancer	2.26e-06	6.34e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PIK3CA—head and neck cancer	2.26e-06	6.33e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—head and neck cancer	2.25e-06	6.32e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HRAS—head and neck cancer	2.25e-06	6.32e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PIK3CA—head and neck cancer	2.25e-06	6.3e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—head and neck cancer	2.25e-06	6.3e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTEN—head and neck cancer	2.24e-06	6.29e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—STAT3—head and neck cancer	2.23e-06	6.26e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PTEN—head and neck cancer	2.23e-06	6.26e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—head and neck cancer	2.23e-06	6.26e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—head and neck cancer	2.22e-06	6.24e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—head and neck cancer	2.22e-06	6.24e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK1—head and neck cancer	2.2e-06	6.18e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EGFR—head and neck cancer	2.2e-06	6.18e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—head and neck cancer	2.2e-06	6.17e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK1—head and neck cancer	2.2e-06	6.16e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EGFR—head and neck cancer	2.2e-06	6.16e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—HRAS—head and neck cancer	2.19e-06	6.14e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—head and neck cancer	2.18e-06	6.12e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—STAT3—head and neck cancer	2.18e-06	6.11e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—head and neck cancer	2.18e-06	6.11e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—head and neck cancer	2.18e-06	6.11e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—head and neck cancer	2.18e-06	6.1e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—HRAS—head and neck cancer	2.18e-06	6.1e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—head and neck cancer	2.17e-06	6.09e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PIK3CA—head and neck cancer	2.14e-06	6e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK3—head and neck cancer	2.13e-06	5.98e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—head and neck cancer	2.12e-06	5.95e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—head and neck cancer	2.12e-06	5.95e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—head and neck cancer	2.11e-06	5.91e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—STAT3—head and neck cancer	2.1e-06	5.89e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—head and neck cancer	2.09e-06	5.87e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—STAT3—head and neck cancer	2.09e-06	5.86e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—HRAS—head and neck cancer	2.09e-06	5.85e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—head and neck cancer	2.08e-06	5.84e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK3—head and neck cancer	2.08e-06	5.84e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—HRAS—head and neck cancer	2.08e-06	5.83e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PIK3CA—head and neck cancer	2.08e-06	5.83e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—head and neck cancer	2.07e-06	5.8e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—head and neck cancer	2.05e-06	5.76e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PIK3CA—head and neck cancer	2.05e-06	5.75e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK1—head and neck cancer	2.03e-06	5.69e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EGFR—head and neck cancer	2.03e-06	5.69e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—head and neck cancer	2.02e-06	5.65e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PIK3CA—head and neck cancer	2.01e-06	5.65e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PIK3CA—head and neck cancer	2.01e-06	5.65e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—head and neck cancer	2.01e-06	5.64e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK3—head and neck cancer	2.01e-06	5.62e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—head and neck cancer	2e-06	5.62e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—STAT3—head and neck cancer	2e-06	5.6e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK3—head and neck cancer	1.99e-06	5.59e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—head and neck cancer	1.99e-06	5.58e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—head and neck cancer	1.98e-06	5.57e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK1—head and neck cancer	1.98e-06	5.55e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EGFR—head and neck cancer	1.98e-06	5.55e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—HRAS—head and neck cancer	1.98e-06	5.55e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—head and neck cancer	1.95e-06	5.47e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—head and neck cancer	1.95e-06	5.47e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—head and neck cancer	1.93e-06	5.42e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—HRAS—head and neck cancer	1.92e-06	5.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—head and neck cancer	1.92e-06	5.39e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PIK3CA—head and neck cancer	1.91e-06	5.36e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK1—head and neck cancer	1.91e-06	5.35e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EGFR—head and neck cancer	1.91e-06	5.35e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PIK3CA—head and neck cancer	1.91e-06	5.35e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK3—head and neck cancer	1.91e-06	5.35e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK1—head and neck cancer	1.9e-06	5.32e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EGFR—head and neck cancer	1.9e-06	5.32e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—HRAS—head and neck cancer	1.9e-06	5.32e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—HRAS—head and neck cancer	1.86e-06	5.23e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—HRAS—head and neck cancer	1.86e-06	5.23e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.86e-06	5.22e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—head and neck cancer	1.85e-06	5.19e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—head and neck cancer	1.84e-06	5.17e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—head and neck cancer	1.84e-06	5.17e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—head and neck cancer	1.84e-06	5.15e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK1—head and neck cancer	1.81e-06	5.09e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EGFR—head and neck cancer	1.81e-06	5.09e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—HRAS—head and neck cancer	1.77e-06	4.96e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—HRAS—head and neck cancer	1.76e-06	4.95e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PIK3CA—head and neck cancer	1.76e-06	4.94e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—head and neck cancer	1.75e-06	4.9e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PIK3CA—head and neck cancer	1.72e-06	4.82e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—head and neck cancer	1.7e-06	4.78e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—head and neck cancer	1.7e-06	4.76e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—head and neck cancer	1.68e-06	4.7e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—head and neck cancer	1.66e-06	4.66e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CA—head and neck cancer	1.66e-06	4.64e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CA—head and neck cancer	1.65e-06	4.62e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—head and neck cancer	1.65e-06	4.62e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—head and neck cancer	1.65e-06	4.62e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—HRAS—head and neck cancer	1.63e-06	4.57e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTEN—head and neck cancer	1.62e-06	4.55e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—head and neck cancer	1.6e-06	4.49e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CA—head and neck cancer	1.6e-06	4.48e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—head and neck cancer	1.59e-06	4.47e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HRAS—head and neck cancer	1.59e-06	4.46e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.58e-06	4.44e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CA—head and neck cancer	1.57e-06	4.41e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—head and neck cancer	1.56e-06	4.38e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—head and neck cancer	1.56e-06	4.37e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TYMS—head and neck cancer	1.55e-06	4.35e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.53e-06	4.3e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HRAS—head and neck cancer	1.53e-06	4.3e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HRAS—head and neck cancer	1.52e-06	4.27e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—head and neck cancer	1.52e-06	4.27e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GPX1—head and neck cancer	1.47e-06	4.12e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HRAS—head and neck cancer	1.46e-06	4.08e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.45e-06	4.08e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—head and neck cancer	1.44e-06	4.03e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—head and neck cancer	1.4e-06	3.94e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—head and neck cancer	1.4e-06	3.94e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—head and neck cancer	1.35e-06	3.79e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—head and neck cancer	1.35e-06	3.77e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—head and neck cancer	1.3e-06	3.66e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—head and neck cancer	1.29e-06	3.63e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—head and neck cancer	1.29e-06	3.61e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTEN—head and neck cancer	1.22e-06	3.43e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.14e-06	3.21e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—head and neck cancer	9.35e-07	2.62e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—head and neck cancer	8.65e-07	2.43e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CA—head and neck cancer	8.63e-07	2.42e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTEN—head and neck cancer	7.54e-07	2.12e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—head and neck cancer	7.05e-07	1.98e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.32e-07	1.49e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—head and neck cancer	4.35e-07	1.22e-06	CbGpPWpGaD
